Collage of photos students in grad gowns sitting on stairs, pharmacist teaching student pharmacist, scientist pointing at screen

Welcome to the UCI School of Pharmacy & Pharmaceutical Sciences

Founded in 2020, the UC Irvine School of Pharmacy & Pharmaceutical Sciences is the first public pharmacy school in the Los Angeles-Orange County region. As part of the Susan & Henry Samueli College of Health Sciences, we actively collaborate with schools and programs in medicine, nursing, and population, public health, and the Susan Samueli Integrative Health Institute to educate, train, and mentor the next generation of pharmaceutical scientists and clinical pharmacists.


Areas of Learning

Offering undergraduate, graduate and professional degrees, the UCI School of Pharmacy & Pharmaceutical Sciences spans a continuum from discovery, development, and delivery of new drugs, devices, and diagnostics all the way to optimizing medication therapy in patients and patient populations.

Strength in Numbers

The UCI School of Pharmacy & Pharmaceutical Sciences was the first in the UC-system to offer an undergraduate degree in pharmaceutical sciences. Today, we are the first public pharmacy school in the Los Angeles-Orange County region. As part of the Susan & Henry Samueli College of Health Sciences, we actively collaborate with schools and programs in medicine, nursing, and population, public health, and the Susan Samueli Integrative Health Institute to educate, train, and mentor the next generation of pharmaceutical scientists and clinical pharmacists.

700+
Students
We are training the next generation of pharmaceutical scientists and clinical pharmacists.
#1
Institution
For students admitted to pharmacy school in California.
37%
First-generation college students
Of our enrolled undergraduate students

In the Media

John Chaput In the Media Headshot
Space Daily, October 9, 2024

Irvine group creates enzyme for efficient synthetic genetic material production

“TNA’s resilience to enzymatic and chemical degradation positions it as the ideal candidate for developing new treatments such as therapeutic aptamers, a promising drug class that binds to target molecules with high specificity. Engineering enzymes that facilitate the discovery of new approaches could address the limitations of antibodies, such as improved tissue penetration, and potentially have an even greater positive impact on human health.” (John Chaput)
John Chaput In the Media Headshot
UCI News, October 8, 2024

UC Irvine-led team engineers new enzyme to produce synthetic genetic material

“This achievement represents a major milestone in the evolution of synthetic biology and opens up exciting possibilities for new therapeutic applications by significantly narrowing the performance gap between natural and artificial enzyme systems. Unlike DNA, TNA’s biostability allows it to be used in a much broader range of treatments, and the new 10-92 TNA polymerase will enable us to reach that goal” (John Chaput)